Drug delivery systems: Anticancer prodrugs and their polymeric conjugates

被引:14
作者
Greenwald, RB
机构
[1] Enzon, Inc., Piscataway, NJ 08854
关键词
D O I
10.1517/13543776.7.6.601
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Prodrugs and their polymeric conjugates (transport forms) offer many promising modalities for new cancer chemotherapies. They present unique opportunities to increase the therapeutic index of a particular drug by exploiting the properties associated with the disease in a predictable fashion. Drugs can be chemically modified with a promoiety to achieve an exclusive selectivity by utilising specific enzymes, fenestrated vasculatures, more acidic environments and other unique properties of the tumour. Additionally, by incorporating a promoiety into existing immunoconjugates, greater efficacy can be achieved.
引用
收藏
页码:601 / 609
页数:9
相关论文
共 61 条
[1]  
AZOULAY M, 1995, ANTI-CANCER DRUG DES, V10, P441
[2]  
BOSSLET K, 1994, CANCER RES, V54, P2151
[3]  
Bundgaard H., 1986, DELIVERY SYSTEMS PEP, P49
[4]   A NOVEL CONNECTOR LINKAGE APPLICABLE IN PRODRUG DESIGN [J].
CARL, PL ;
CHAKRAVARTY, PK ;
KATZENELLENBOGEN, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (05) :479-480
[5]  
CONOVER CD, UNPUB CIRCULATORY RE
[6]   PHASE-I CLINICAL AND PHARMACOKINETIC TRIAL OF DEXTRAN CONJUGATED DOXORUBICIN (AD-70, DOX-OXD) [J].
DANHAUSERRIEDL, S ;
HAUSMANN, E ;
SCHICK, HD ;
BENDER, R ;
DIETZFELBINGER, H ;
RASTETTER, J ;
HANAUSKE, AR .
INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) :187-195
[7]  
DROBNIK J, 1989, Advanced Drug Delivery Reviews, V3, P229, DOI 10.1016/0169-409X(89)90012-4
[8]   DRUG POLYMER CONJUGATES - POTENTIAL FOR IMPROVED CHEMOTHERAPY [J].
DUNCAN, R .
ANTI-CANCER DRUGS, 1992, 3 (03) :175-210
[9]   POLYMER CONJUGATES - PHARMACOKINETIC CONSIDERATIONS FOR DESIGN AND DEVELOPMENT [J].
DUNCAN, R ;
SPREAFICO, F .
CLINICAL PHARMACOKINETICS, 1994, 27 (04) :290-306
[10]   Synthesis and antitumor activity of the immunoconjugate BR96-Dox [J].
Firestone, RA ;
Willner, D ;
Hofstead, SJ ;
King, HD ;
Kaneko, T ;
Braslawsky, GR ;
Greenfield, RS ;
Trail, PA ;
Lasch, SJ ;
Henderson, AJ ;
Casazza, AM ;
Hellstrom, I .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :251-259